Phase 1 Trial Results for 108 Participants in Wuhan on the 16th of Last Month
If Valid Results Emerge, Phase 2 and 3 Global Collaboration Needed

[Asia Economy Reporter Cho Young-shin] Chinese health authorities are scheduled to announce the results of the Phase 1 clinical trial of the novel coronavirus (COVID-19) vaccine within this month, according to a report by the Hong Kong South China Morning Post (SCMP) on the 2nd.


Super Influenza Vaccine

Super Influenza Vaccine

View original image

SCMP added that Chinese health authorities hope for global collaboration on Phase 2 and Phase 3 clinical trials to verify the vaccine's safety and efficacy.


Chen Wei, the top virologist at the Chinese Academy of Military Sciences, stated, "Phases 2 and 3 require numerous test subjects, and conducting these trials in countries severely affected by the virus will help produce faster and more accurate results." He also mentioned, "Currently, there are not enough confirmed cases for additional vaccine testing." He said that if 10,000 people are tested and only 100 develop immunity, the vaccine would not have sufficient value.


According to SCMP, he said, "If the initial results prove that the vaccine is safe and effective, China will test its efficacy overseas."


Tao Lina, a former official at the Shanghai Center for Disease Control and Prevention, expressed the opinion that "it would be good to conduct future clinical trials in scientifically advanced countries such as the United Kingdom and Germany."


He said that while the United States might be reluctant to cooperate with China, collaboration with severely affected countries like the UK could be possible.


The Phase 1 clinical trial was conducted on the 16th of last month in Wuhan, China, with a total of 108 participants.


SCMP also introduced expert opinions that it would be ideal for medical personnel from China and the United States to collaborate in developing the vaccine.



Zhou Zhiming, a military analyst based in Beijing, said, "The whole world is facing the crisis of COVID-19," and "China and the United States must jointly fight the epidemic," according to SCMP.


This content was produced with the assistance of AI translation services.

© The Asia Business Daily(www.asiae.co.kr). All rights reserved.

Today’s Briefing